---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-377696"
form_type: "8-K"
ticker: "BMRN"
cik: "0001048477"
company_name: "BIOMARIN PHARMACEUTICAL INC"
filed_at: "2026-09-01T13:23:17+00:00"
generated_at: "2026-09-01T13:24:12.255302+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BioMarin completes acquisition of Alesta Therapeutics B.V.

## Summary
- Completed share purchase of Alesta Therapeutics on Aug 31, 2026; Alesta now wholly owned subsidiary.
- Acquisition follows Share Purchase Agreement first filed Aug 18, 2026; no new deal terms disclosed.
- BioMarin (BMRN) expands portfolio via Alesta; purchase price not stated in this 8-K.

## SEC filing metadata
- accession: 0001193125-26-377696
- form_type: 8-K
- ticker: BMRN
- cik: 0001048477
- company_name: BIOMARIN PHARMACEUTICAL INC
- filed_at: 2026-09-01T13:23:17+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1048477/000119312526377696/0001193125-26-377696-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1048477/000119312526377696/d110660d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-377696
- JSON: https://secwatch.observer/filing/0001193125-26-377696.json
- Plain text: https://secwatch.observer/filing/0001193125-26-377696.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.